Results 11 to 20 of about 436,080 (341)

Prospects of bacteriophage collections in disinfectant applications [PDF]

open access: yesVeterinary World, 2022
Background and Aim: The search and development of disinfectants is promising worldwide. However, there are currently no international regulations governing the testing and registration of germicidal agents. Moreover, the number of safety requirements for
Samat Serikovich Issabekov   +4 more
doaj   +1 more source

Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG

open access: yesMicroorganisms, 2021
Background: The investigation of the antibody response to SARS-CoV-2 represents a key aspect in facing the COVID-19 pandemic. In the present study, we compared the new Immundiagnostik IDK® anti-SARS-CoV-2 S1 IgG assay with four widely-used commercial ...
Kirsten Alexandra Eberhardt   +16 more
doaj   +1 more source

Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant Recipients

open access: yesMicroorganisms, 2021
Dialysis patients and kidney transplant (KTX) recipients suffer from an impaired immune system and show a decreased response to the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) vaccination.
Patrick Affeldt   +23 more
doaj   +1 more source

Mixed viral infection constrains the genome formula of multipartite cucumber mosaic virus

open access: yesFrontiers in Virology, 2023
Many plant viruses have a multipartite organization, with multiple genome segments packaged into separate virus particles. The genome formula describes the relative frequencies of all viral genome segments, and previous work suggests rapid changes in ...
Dieke Boezen   +7 more
doaj   +1 more source

Moving beyond Titers

open access: yesVaccines, 2022
Vaccination to prevent and even eliminate disease is amongst the greatest achievements of modern medicine. Opportunities remain in vaccine development to improve protection across the whole population. A next step in vaccine development is the detailed molecular characterization of individual humoral immune responses against a pathogen, especially the ...
Benjamin D. Brooks   +4 more
openaire   +3 more sources

Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination

open access: yesVaccines, 2021
The humoral immunity after SARS-CoV-2 infection or vaccination was examined. Convalescent sera after infection with variants of concern (VOCs: B.1.1.7, n = 10; B.1.351, n = 1) and sera from 100 vaccinees (Pfizer/BioNTech, BNT162b2, n = 33; Moderna, mRNA ...
Franziska Neumann   +6 more
doaj   +1 more source

The Influence of β-1,3-1,6-Glucans on Rabies Vaccination Titers in Cats

open access: yesVeterinary Sciences, 2020
β-glucans have been shown to stimulate the immune system in several animal species. The aim of this study was to evaluate the immune stimulation capacity of a fully formulated diet with β-1,3-1,6-glucans in cats, by assessing the rabies antibody titer ...
John Byrne   +4 more
doaj   +1 more source

Effect of Newcastle disease virus level of infection on embryonic length, embryonic death, and protein profile changes [PDF]

open access: yesVeterinary World, 2018
Background and Aim: Newcastle disease virus (NDV) is an obligate intracellular parasite. Virus can only live on living cells. The embryonated chicken eggs (ECEs) are one of the growth media of virus that is a cheap, easy to do, and accurate for showing ...
Dahliatul Qosimah   +3 more
doaj   +1 more source

Improving the Yield and Quality of Daptomycin in Streptomyces roseosporus by Multilevel Metabolic Engineering

open access: yesFrontiers in Microbiology, 2022
Daptomycin is a cyclic lipopeptide antibiotic with a significant antibacterial action against antibiotic-resistant Gram-positive bacteria. Despite numerous attempts to enhance daptomycin yield throughout the years, the production remains unsatisfactory ...
Zhong-Yuan Lyu   +17 more
doaj   +1 more source

Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Introduction Cancer patients are more vulnerable to coronavirus disease 2019 (COVID-19) owing to their compromised immune status. However, data regarding COVID-19 vaccine safety and immune response in cancer patients are scarce.
Piyarat Limpawittayakul   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy